Indication

Chikungunya virus vaccination

Chikungunya virus vaccination refers to active immunization indicated for the prevention of disease caused by the chikungunya virus, an arthropod-borne alphavirus transmitted primarily by *Aedes* mosquitoes. Read more about Chikungunya virus vaccination

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Chikungunya virus vaccination therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Chikungunya virus vaccination preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chikungunya virus vaccination.

Chikungunya virus vaccination refers to active immunization indicated for the prevention of disease caused by the chikungunya virus, an arthropod-borne alphavirus transmitted primarily by *Aedes* mosquitoes.

Infection targets multiple organ systems, characteristically manifesting as an acute febrile syndrome accompanied by severe, polyarticular joint pain, myalgia, headache, and maculopapular rash.

A prominent pathophysiologic feature of chikungunya disease is persistent synovial inflammation, which can lead to debilitating, chronic arthralgia or arthritis lasting months to years.

Immunization is primarily indicated for adolescents and adults at increased risk of exposure, including travelers to regions with active outbreaks and laboratory personnel handling the virus.

Personalize your experience

Follow Chikungunya virus vaccination and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it